Skip to main content

Author: Bill Snyder

Omicron evades some but not all monoclonal antibodies: study

Jan. 20, 2022—A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.

Read more


Pozzi elected president of Society for Matrix Biology

Jan. 20, 2022—Vanderbilt's Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health.

Read more


Ensuring the “best possible” medication history

Jan. 18, 2022—About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices.

Read more


The role of integrins in kidney “integrity”

Jan. 13, 2022—Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered.

Read more


Study seeks to refine head and neck cancer treatment options

Jan. 13, 2022—  by Bill Snyder Researchers at Case Western Reserve University and Vanderbilt University Medical Center are pioneering the use of computer-aided image analysis to improve the prognostication and treatment of head and neck cancer. Each year in the United States, approximately 16,000 patients are diagnosed with a form of head-and-neck cancer called oropharyngeal squamous cell...

Read more


Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

Jan. 10, 2022—Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center, has announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU.

Read more


Study explores how bacteria become drug resistant

Jan. 6, 2022—Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs.

Read more


Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness

Dec. 23, 2021—On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.

Read more


“Atlas” of lung development may aid efforts to heal premature lungs

Dec. 20, 2021—Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time.

Read more


Silver appointed to national committee assessing human requirements for energy intake and expenditure

Dec. 17, 2021—Vanderbilt's Heidi Silver, PhD, RDN, MS, has been appointed to an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine to assess the human requirements for energy intake and expenditure.

Read more


Two VUMC papers named among genomic medicine’s top 10

Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.

Read more


“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more